1
|
Mays EA, Ellis EB, Hussain Z, Parajuli P, Sundararaghavan HG. Enzyme-Mediated Nerve Growth Factor Release from Nanofibers Using Gelatin Microspheres. Tissue Eng Part A 2023; 29:333-343. [PMID: 37016821 DOI: 10.1089/ten.tea.2022.0205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/06/2023] Open
Abstract
Spinal cord injury is a complex environment, with many conflicting growth factors present at different times throughout the injury timeline. Delivery of multiple growth factors has received mixed results, highlighting a need to consider the timing of delivery for possibly antagonistic growth factors. Cell-mediated degradation of delivery vehicles for delayed release of growth factors offers an attractive way to exploit the highly active immune response in the spinal cord injury environment. In this study, growth factor-loaded gelatin microspheres (GMS) combined with methacrylated hyaluronic acid (MeHA) were electrospun to create GMS fibers (GMSF) for delayed release of growth factors (GFs). GMS were successfully combined with MeHA while electrospinning, with an average fiber diameter of 365 ± 10 nm and 44% ± 8% fiber alignment. GMSF with nerve growth factor (NGF) was tested on dissociated chick dorsal root ganglia cells. We further tested the effect of M1 macrophage-conditioned media (M1CM) to simulate macrophage invasion after spinal cord injury for cell-mediated degradation. We hypothesized that neurons grown on GMSF with loaded NGF would exhibit longer neurites in M1CM, showing a release of functional NGF, as compared with controls. GMSF in M1CM was significantly different from MeHA in serum-free media (SFM) and M0-conditioned media (M0CM), as well as GMSF in M0CM (p < 0.05). Moreover, GMSF + NGF in all media conditions were significantly different from MeHA in SFM and M0CM (p < 0.05). The goal of this study was to develop a biomaterial system where drug delivery is triggered by immune response, allowing for more control and longer exposure to encapsulated drugs. The spinal cord injury microenvironment is known to have a robust immune response, making this immune-medicated drug release system particularly significant for directed repair.
Collapse
Affiliation(s)
- Elizabeth A Mays
- Department of Biomedical Engineering, Wayne State University, Detroit, Michigan, USA
| | - Eric B Ellis
- Department of Chemical Engineering and Materials Science, Wayne State University, Detroit, Michigan, USA
| | - Zahin Hussain
- School of Medicine, Michigan State University, East Lansing, Michigan, USA
| | - Prahlad Parajuli
- Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan, USA
| | | |
Collapse
|
2
|
Mays EA, Kallakuri SS, Sundararaghavan HG. Heparin-hyaluronic acid nanofibers for growth factor sequestration in spinal cord repair. J Biomed Mater Res A 2020; 108:2023-2031. [PMID: 32319183 DOI: 10.1002/jbm.a.36962] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2019] [Revised: 03/24/2020] [Accepted: 03/28/2020] [Indexed: 12/18/2022]
Abstract
Growth factor (GF) delivery is a common strategy for spinal cord injury repair, however, GF degradation can impede long-term therapies. GF sequestration via heparin is known to protect bioactivity after delivery. We tested two heparin modifications, methacrylated heparin and thiolated heparin, and electrospun these with methacrylated hyaluronic acid (MeHA) to form HepMAHA and HepSHHA nanofibers. For loaded conditions, MeHA, HepMAHA, and HepSHHA fibers were incubated with soluble basic fibroblast growth factor (bFGF) or nerve growth factor (NGF) and rinsed with PBS. Control groups were hydrated in PBS. L929 fibroblast proliferation was analyzed after 24 hr of culture in either growth media or bFGF-supplemented media. Dissociated chick dorsal root ganglia neurites were measured after 3 days of cell culture in serum free media (SFM) or NGF-supplemented SFM (SFM + NGF). In growth media, fibroblast proliferation was significantly increased in loaded HepMAHA (α < .05) compared to other groups. In SFM, loaded HepMAHA had the longest average neurite length compared to all other groups. In SFM + NGF, HepMAHA and HepSHHA had increased neurite lengths compared to MeHA, regardless of loading (α < .01), suggesting active sequestration of soluble NGF. HepMAHA is a promising biomaterial for sequestering released GFs in a spinal cord injury environment and will be combined with GF filled microspheres for future studies.
Collapse
Affiliation(s)
- Elizabeth A Mays
- Biomedical Engineering, Wayne State University, Detroit, Michigan, USA
| | | | | |
Collapse
|
3
|
Wang Q, Cai H, Hu Z, Wu Y, Guo X, Li J, Wang H, Liu Y, Liu Y, Xie L, Xu K, Xu H, He H, Zhang H, Xiao J. Loureirin B Promotes Axon Regeneration by Inhibiting Endoplasmic Reticulum Stress: Induced Mitochondrial Dysfunction and Regulating the Akt/GSK-3β Pathway after Spinal Cord Injury. J Neurotrauma 2019; 36:1949-1964. [PMID: 30543130 DOI: 10.1089/neu.2018.5966] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Axon retraction greatly limits functional recovery after spinal cord injury (SCI) and neuron polarization, which affects processes including axon formation and development, is a promising target for promoting axon regeneration. Increasing microtubule stability has been demonstrated to improve intrinsic axon regeneration processes and is critically related to endoplasmic reticulum (ER)-mitochondria interactions. We used real-time polymerase chain reaction, Western blotting, and immunofluorescence to screen a variety of natural compounds, and found that Loureirin B (LrB) effectively promoted neuron polarization and axon regeneration in vitro and in vivo. LrB significantly inhibited ER stress and thereby promoted mitochondrial functions by regulating mitochondrial fusion. Further, LrB reactivated the Akt/GSK-3β pathway, which plays critical roles in cell survival and microtubule stabilization. Taken together, our results suggest that the effects of LrB on neuron regeneration involve the inhibition of ER stress-induced mitochondrial dysfunction and activation of the Akt/GSK-3β pathway, which further promotes microtubule stabilization. LrB may therefore be a promising candidate for facilitating recovery following SCI.
Collapse
Affiliation(s)
- Qingqing Wang
- 1 Department of Orthopedics, Second Affiliated Hospital and Yuying Children's Hospital, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.,2 Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China
| | - Hanxiao Cai
- 1 Department of Orthopedics, Second Affiliated Hospital and Yuying Children's Hospital, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.,2 Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China
| | - Zhenxin Hu
- 1 Department of Orthopedics, Second Affiliated Hospital and Yuying Children's Hospital, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.,2 Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China
| | - Yanqing Wu
- 3 The Institute of Life Sciences, Wenzhou University, Wenzhou, China
| | - Xin Guo
- 2 Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China
| | - Jiawei Li
- 2 Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China
| | - Haoli Wang
- 1 Department of Orthopedics, Second Affiliated Hospital and Yuying Children's Hospital, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China
| | - Yani Liu
- 1 Department of Orthopedics, Second Affiliated Hospital and Yuying Children's Hospital, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China
| | - Yanlong Liu
- 2 Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China
| | - Ling Xie
- 2 Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China
| | - Ke Xu
- 3 The Institute of Life Sciences, Wenzhou University, Wenzhou, China
| | - Huazi Xu
- 1 Department of Orthopedics, Second Affiliated Hospital and Yuying Children's Hospital, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China
| | - Huacheng He
- 4 College of Chemistry and Materials Engineering, Wenzhou University, Wenzhou, China
| | - Hongyu Zhang
- 2 Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China
| | - Jian Xiao
- 1 Department of Orthopedics, Second Affiliated Hospital and Yuying Children's Hospital, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.,2 Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China
| |
Collapse
|